Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up

Erstveröffentlichung
2008Authors
Zander, Axel
Schmoor, Claudia
Kröger, Nicolaus
Krüger, Winfried
Möbus, Volker
Wissenschaftlicher Artikel
Published in
Annals of Oncology ; 19 (2008), 6. - S. 1082-1089. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1093/annonc/mdn023Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: breast cancer | high risk | randomized study | FINAL ANALYSIS | TRANSPLANTATION | THERAPY | DENSE | CYCLOPHOSPHAMIDE[DDC subject group]: DDC 610 / Medicine & health